UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Unicycive Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$3.51+0.15 (+4.46%)
Close on Oct 19, 2026
- Market cap
- $94.48M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Unicycive Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 28, 2026 | Sep 29, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 2, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 19, 2026 | Jun 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 19, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 6, 2026 | Apr 6, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 28, 2025 | Oct 28, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 15, 2025 | Aug 18, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 15, 2025 | Aug 15, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2025 | Jul 8, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 21, 2025 | May 21, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 9, 2025 | Apr 30, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Mar 31, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2025 | Jan 7, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 11, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2024 | Sep 25, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2024 | Jul 15, 2024 | SEC EDGAR |